{"id":1199,"date":"2025-07-21T14:56:23","date_gmt":"2025-07-21T14:56:23","guid":{"rendered":"https:\/\/admit-therapeutics.com\/?p=1199"},"modified":"2025-09-04T06:20:26","modified_gmt":"2025-09-04T06:20:26","slug":"admit-therapeutics-sl-one-of-the-10-most-disruptive-companies-in-catalonia-according-to-accio","status":"publish","type":"post","link":"https:\/\/admit-therapeutics.com\/en\/admit-therapeutics-sl-one-of-the-10-most-disruptive-companies-in-catalonia-according-to-accio\/","title":{"rendered":"ADmit Therapeutics SL, one of the 10 most disruptive companies in Catalonia, according to ACCI\u00d3"},"content":{"rendered":"\n<p><strong>Barcelona, July 16, 2025<\/strong>&nbsp;\u2014 The company has been recognized as one of the startups and companies awarded the&nbsp;<em>\u2018Catalonia Exponential Leaders\u2019<\/em>&nbsp;distinction by ACCI\u00d3, which acknowledges pioneers in the field of disruptive innovation for their ability to generate a positive impact on society beyond their business models, as well as their potential for exponential growth and adoption of disruptive technologies.<\/p>\n\n\n\n<p>The most disruptive companies were announced this Wednesday as part of\u00a0<em>Exponential Day<\/em>, which focused on the potential of artificial intelligence and data for businesses.<\/p>\n\n\n\n<p>Our company represents biotechnological innovation brought into clinical practice and digital transformation. We combine the capabilities of artificial intelligence with the analysis of clinical parameters and new biological markers resulting from our own research, placing Alzheimer&#8217;s disease at the center of the study of cellular bioenergetics. This also enables us to pioneer the analysis and prediction of cellular aging in a unique and groundbreaking way.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.accio.gencat.cat\/ca\/serveis\/innovacio\/innovacio-oberta-disruptiva\/catalonia-exponential-leaders\">https:\/\/www.accio.gencat.cat\/ca\/serveis\/innovacio\/innovacio-oberta-disruptiva\/catalonia-exponential-leaders<\/a><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/admit-therapeutics.com\/wp-content\/uploads\/2025\/07\/CEL_digital_1_1-1024x1024.webp\" alt=\"\" class=\"wp-image-1202\" srcset=\"https:\/\/admit-therapeutics.com\/wp-content\/uploads\/2025\/07\/CEL_digital_1_1-1024x1024.webp 1024w, https:\/\/admit-therapeutics.com\/wp-content\/uploads\/2025\/07\/CEL_digital_1_1-300x300.webp 300w, https:\/\/admit-therapeutics.com\/wp-content\/uploads\/2025\/07\/CEL_digital_1_1-150x150.webp 150w, https:\/\/admit-therapeutics.com\/wp-content\/uploads\/2025\/07\/CEL_digital_1_1-768x768.webp 768w, https:\/\/admit-therapeutics.com\/wp-content\/uploads\/2025\/07\/CEL_digital_1_1.webp 1080w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona, July 16, 2025&nbsp;\u2014 The company has been recognized as one of the startups and companies awarded the&nbsp;\u2018Catalonia Exponential Leaders\u2019&nbsp;distinction by ACCI\u00d3, which acknowledges pioneers in the field of disruptive innovation for their ability to generate a positive impact on society beyond their business models, as well as their potential for exponential growth and adoption [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1199","post","type-post","status-publish","format-standard","hentry","category-sin-categorizar"],"acf":[],"_links":{"self":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts\/1199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/comments?post=1199"}],"version-history":[{"count":1,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts\/1199\/revisions"}],"predecessor-version":[{"id":1204,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/posts\/1199\/revisions\/1204"}],"wp:attachment":[{"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/media?parent=1199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/categories?post=1199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/admit-therapeutics.com\/en\/wp-json\/wp\/v2\/tags?post=1199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}